We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




AI Identifies Severe Aortic Stenosis from Routine ECGs

By HospiMedica International staff writers
Posted on 02 Sep 2022
Print article
Image: AI algorithm uses routine echocardiograms to identify aortic stenosis patients at high risk of death (Photo courtesy of Pexels)
Image: AI algorithm uses routine echocardiograms to identify aortic stenosis patients at high risk of death (Photo courtesy of Pexels)

Aortic stenosis is the most common primary valve lesion requiring surgery or transcatheter intervention in Europe and North America. Prevalence is rapidly increasing due to ageing populations. Guidelines strongly advise early intervention in all symptomatic patients with severe aortic stenosis due to the dismal prognosis. Approximately 50% of untreated patients with aortic stenosis die in the first two years after symptoms appear. Echocardiography is used to assess severity, namely with peak velocity, mean pressure gradient and aortic valve area. However, there is increasing evidence that elevated mortality risk extends beyond current diagnostic definitions and more patients should be considered for aortic valve replacement. Now, a novel artificial intelligence (AI) algorithm uses routine echocardiograms to identify aortic stenosis patients at high risk of death who could benefit from treatment.

Researchers at the University of Notre Dame, Australia (Fremantle, Australia) examined whether an AI algorithm developed from echocardiographic parameters routinely used in clinical practice could identify moderate-to-severe and severe aortic stenosis phenotypes associated with increasing five-year mortality. The proprietary AI-Decision Support Algorithm (AI-DSA) used was trained using data from the National Echo Database of Australia (NEDA), which contains more than 1,000,000 echocardiograms from over 630,000 patients and is linked to mortality information. The algorithm was also trained to ensure all guideline-defined severe aortic stenosis was detected. Training was performed using 70% of the NEDA data, which were randomly selected.

Using the remaining 30% of NEDA data, the researchers compared five-year death rates in patients with the moderate-to-severe and severe aortic stenosis phenotypes with five-year death rates in patients without significant risk of severe aortic stenosis. Out of 179,054 individuals, the AI-DSA identified 2,606 (1.4%) with a moderate-to-severe phenotype and 4,622 (2.5%) with a severe phenotype. Of those with a severe phenotype, 3,566 (77.2%) met guideline criteria for severe aortic stenosis.

The five-year mortality rate was 56.2% in patients with the moderate-to-severe phenotype and 67.9% in those with the severe phenotype. Those without either phenotype (the reference group) had a 22.9% five-year mortality rate. Compared with the reference group, the age- and sex- adjusted odds ratio (OR) for all-cause mortality was 1.82 (95% confidence interval [CI] 1.63–2.02) and 2.80 (95% CI 2.57–3.06) for patients with the moderate-to-severe and severe phenotypes, respectively. Within the severe aortic stenosis phenotype identified by the AI-DSA (4,622; 2.5%), those that met current guidelines (77%) had a five-year mortality of 69.1%. The additional population identified by the AI-DSA with a severe phenotype, but who do not meet current guidelines, had a mortality rate of 64.4%.

“This proprietary AI algorithm picks up patients with a high risk (and all patients within current guidelines) of dying within five years that may be missed by conventional definitions. The findings suggest that the AI algorithm could be used in clinical practice to alert physicians to patients who should undergo further investigations to determine if they qualify for aortic valve replacement,” said principal investigator Professor Geoffrey Strange of the University of Notre Dame, Australia. “Given the rising prevalence of aortic stenosis and its impact on mortality, it is time to revisit the practice of watchful waiting and consider more proactive attempts to identify those at risk. More research is needed to determine if aortic valve replacement improves survival and quality of life in patients identified by the AI-DSA as having a high risk of mortality, but who do not meet current guideline definitions.”

Related Links:
University of Notre Dame, Australia 

Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
New
High Frequency X-Ray Generator
SHFR
New
Surgical Light
HyLED 600 Series
New
Electric Suction Machine
YX980D

Print article

Channels

Critical Care

view channel
Image: The advanced electronic skin could enable multiplex healthcare monitoring (Photo courtesy of Terasaki Institute)

First-of-Its-Kind Electronic Skin Patch Enables Advanced Health Care Monitoring

For some time now, electronic skin (E-skin) patches have been used to monitor bodily physiological and chemical indicators of health. Such monitors, placed on the skin, are capable of measuring various... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)

Artificial Intelligence (AI) Could Save U.S. Healthcare Industry USD 360 Billion Annually

The wider adoption of artificial intelligence (AI) in healthcare could save the U.S. up to USD 360 billion annually although its uptake in the industry is presently limited owing to the absence of trust... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.